Evaluation of Drug Load and Polymer by Using a 96-Well Plate Vacuum Dry System for Amorphous Solid Dispersion Drug Delivery
It is well recognized that poor dissolution rate and solubility of drug candidates are key limiting factors for oral bioavailability. While numerous technologies have been developed to enhance solubility of the drug candidates, poor water solubility continuously remains a challenge for drug delivery...
Saved in:
Published in | AAPS PharmSciTech Vol. 13; no. 2; pp. 713 - 722 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Boston
Springer US
01.06.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | It is well recognized that poor dissolution rate and solubility of drug candidates are key limiting factors for oral bioavailability. While numerous technologies have been developed to enhance solubility of the drug candidates, poor water solubility continuously remains a challenge for drug delivery. Among those technologies, amorphous solid dispersions (SD) have been successfully employed to enhance both dissolution rate and solubility of poorly water-soluble drugs. This research reports a high-throughput screening technology developed by utilizing a 96-well plate system to identify optimal drug load and polymer using a solvent casting approach. A minimal amount of drug was required to evaluate optimal drug load in three different polymers with respect to solubility improvement and solid-state stability of the amorphous drug–polymer system. Validation of this method was demonstrated with three marketed drugs as well as with one internal compound. Scale up of the internal compound SD by spray drying further confirmed the validity of this method, and its quality was comparable to a larger scale process. Here, we demonstrate that our system is highly efficient, cost-effective, and robust to evaluate the feasibility of spray drying technology to produce amorphous solid dispersions. |
---|---|
AbstractList | It is well recognized that poor dissolution rate and solubility of drug candidates are key limiting factors for oral bioavailability. While numerous technologies have been developed to enhance solubility of the drug candidates, poor water solubility continuously remains a challenge for drug delivery. Among those technologies, amorphous solid dispersions (SD) have been successfully employed to enhance both dissolution rate and solubility of poorly water-soluble drugs. This research reports a high-throughput screening technology developed by utilizing a 96-well plate system to identify optimal drug load and polymer using a solvent casting approach. A minimal amount of drug was required to evaluate optimal drug load in three different polymers with respect to solubility improvement and solid-state stability of the amorphous drug-polymer system. Validation of this method was demonstrated with three marketed drugs as well as with one internal compound. Scale up of the internal compound SD by spray drying further confirmed the validity of this method, and its quality was comparable to a larger scale process. Here, we demonstrate that our system is highly efficient, cost-effective, and robust to evaluate the feasibility of spray drying technology to produce amorphous solid dispersions. |
Author | Chiang, Po-Chang Sambrone, Amy Cui, Yong Ran, Yingqing Chan, Connie Chou, Kang-Jye Hart, Ryan |
Author_xml | – sequence: 1 givenname: Po-Chang surname: Chiang fullname: Chiang, Po-Chang email: Chiang.pochang@gene.com organization: Global Research and Development, SMPS, Genentech Inc – sequence: 2 givenname: Yingqing surname: Ran fullname: Ran, Yingqing organization: Global Research and Development, SMPS, Genentech Inc – sequence: 3 givenname: Kang-Jye surname: Chou fullname: Chou, Kang-Jye organization: Global Research and Development, SMPS, Genentech Inc – sequence: 4 givenname: Yong surname: Cui fullname: Cui, Yong organization: Global Research and Development, SMPS, Genentech Inc – sequence: 5 givenname: Amy surname: Sambrone fullname: Sambrone, Amy organization: Global Research and Development, SMPS, Genentech Inc – sequence: 6 givenname: Connie surname: Chan fullname: Chan, Connie organization: Global Research and Development, SMPS, Genentech Inc – sequence: 7 givenname: Ryan surname: Hart fullname: Hart, Ryan organization: Global Research and Development, SMPS, Genentech Inc |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22562615$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkU1v1DAQhi1URD_gB3BBPnIJeGzHWV-Qqm75kFaiUikcLSeZ3bpy7MVOVor65_GypSoXxMkjzTOv5533lByFGJCQ18DeAWeL9xk4l7piwCvd6Lriz8gJ1IJVWgt-9KQ-Jqc53zHGBWjxghxzXiuuoD4h95c76yc7uhhoXNNlmjZ0FW1PbejpVfTzgIm2M73JLmyopVpVP9B7euXtiPS77aZpKFMzvZ7ziANdx0TPh5i2t3HK9Dp619Oly1tMef_Fb_0lerfDNL8kz9fWZ3z18J6Rm4-X3y4-V6uvn75cnK-qrpYwFmtKNKJbqIa3Xa-tlQBMt0ow5A0Trai5qhnIvuUW-06q2jZC9ogAHbZoxRn5cNDdTu1QCAxjst5skxtsmk20zvzdCe7WbOLOCKGkZKwIvH0QSPHnhHk0g8tdOYMNWGwaABBcwkL_B8pgIcq2TBcUDmiXYs4J148bATP7fM0hX1PyNft8DS8zb55aeZz4E2gB-AHIpRU2mMxdnFIo5_2H6i_c1rKz |
CitedBy_id | crossref_primary_10_1016_j_xphs_2017_11_006 crossref_primary_10_1016_j_ejps_2018_08_035 crossref_primary_10_1016_j_ijpharm_2015_07_037 crossref_primary_10_1021_ac501426f crossref_primary_10_1016_j_ijpharm_2013_04_040 crossref_primary_10_1208_s12248_014_9590_y crossref_primary_10_1002_jps_24541 crossref_primary_10_3109_03639045_2015_1018274 crossref_primary_10_3390_pharmaceutics10010029 crossref_primary_10_1016_j_jddst_2020_102196 crossref_primary_10_1248_cpb_c18_00644 crossref_primary_10_1080_03639045_2021_1892747 crossref_primary_10_1016_j_ejpb_2013_01_009 crossref_primary_10_1208_s12249_021_02160_1 crossref_primary_10_1007_s11095_017_2174_7 crossref_primary_10_3390_pharmaceutics11120625 crossref_primary_10_1208_s12249_017_0861_7 crossref_primary_10_3390_pr6080129 crossref_primary_10_1007_s10856_015_5437_z crossref_primary_10_1016_j_addr_2020_11_009 crossref_primary_10_1016_j_prosdent_2020_03_027 crossref_primary_10_1021_acs_molpharmaceut_5b00688 crossref_primary_10_1080_10837450_2018_1534861 crossref_primary_10_1080_10837450_2019_1616208 crossref_primary_10_1016_j_ijpharm_2013_06_064 crossref_primary_10_4155_tde_14_101 crossref_primary_10_3390_pharmaceutics12111019 crossref_primary_10_1208_s12248_013_9519_x crossref_primary_10_1016_j_xphs_2016_04_003 crossref_primary_10_1208_s12248_013_9469_3 crossref_primary_10_3390_ijms18050989 crossref_primary_10_3390_ph11030081 crossref_primary_10_3390_pharmaceutics11050227 crossref_primary_10_1016_j_ijpharm_2013_07_013 crossref_primary_10_1016_j_xphs_2017_09_024 |
Cites_doi | 10.1002/jps.20799 10.1038/nrd1550 10.1021/mp800042d 10.1007/s11095-008-9565-8 10.1021/mp8000793 10.1002/jps.20477 10.1021/mp800203k 10.1208/s12249-009-9319-x 10.1023/A:1007516718048 10.1016/S1056-8719(00)00107-6 10.3109/03639048509056895 10.1007/s11095-004-1882-y 10.1007/s11095-009-9852-z 10.1016/S0378-5173(97)00367-0 10.1016/S0169-409X(00)00129-0 10.1002/jps.3080090114 10.1002/jps.20474 10.1021/mp900050c 10.1111/j.1747-0285.2005.00314.x 10.1615/CritRevTherDrugCarrierSyst.v21.i3.10 10.1002/jps.21782 10.1016/S0378-5173(01)00709-8 10.1023/A:1012167410376 10.1021/ml200025q 10.1016/j.rvsc.2010.02.002 10.1016/j.ijpharm.2007.09.042 10.1016/S0939-6411(00)00076-X 10.1023/B:PHAM.0000045226.42859.b8 10.1016/S0378-5173(02)00316-2 10.1002/jps.2600840814 |
ContentType | Journal Article |
Copyright | American Association of Pharmaceutical Scientists 2012 |
Copyright_xml | – notice: American Association of Pharmaceutical Scientists 2012 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 7QO 8FD FR3 P64 5PM |
DOI | 10.1208/s12249-012-9795-2 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic Biotechnology Research Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic Engineering Research Database Biotechnology Research Abstracts Technology Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitleList | MEDLINE Engineering Research Database |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1530-9932 |
EndPage | 722 |
ExternalDocumentID | 10_1208_s12249_012_9795_2 22562615 |
Genre | Validation Studies Journal Article |
GroupedDBID | --- -56 -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 203 23M 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 4.4 406 408 40D 40E 53G 5GY 5VS 67N 6J9 6NX 875 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AAFGU AAHNG AAIAL AAJKR AAKDD AANXM AANZL AAPBV AARHV AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYQN AAYTO ABDZT ABECU ABFGW ABFTV ABHLI ABHQN ABJNI ABJOX ABKAS ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABWNU ABXPI ACBMV ACBRV ACBXY ACBYP ACGFO ACGFS ACHSB ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACREN ACSNA ACTTH ACVWB ACWMK ADBBV ADHHG ADHIR ADINQ ADKNI ADKPE ADMDM ADOXG ADRFC ADURQ ADYFF ADYOE ADZKW AEBTG AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFGCZ AFLOW AFNRJ AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGGBP AGJBK AGMZJ AGQMX AGWZB AGYKE AHAVH AHBYD AHKAY AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG AOIJS ARMRJ AXYYD B-. BA0 BAWUL BDATZ BGNMA C1A CAG COF CS3 CSCUP DDRTE DIK DNIVK DPUIP E3Z EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GX1 HG6 HH5 HMJXF HRMNR HYE HZ~ IJ- IKXTQ IWAJR IXC IXD I~X I~Z J-C J0Z JBSCW JZLTJ KOV KPH LLZTM M4Y MA- NPVJJ NQJWS NU0 O9- O93 O9I O9J OK1 OVD P2P PF0 PT4 QOR QOS R89 R9I ROL RPM RPX RSV S16 S1Z S27 S3A S3B SAP SBL SHX SISQX SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZN T13 TEORI TR2 TSG TSV TUC U2A U9L UG4 UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 XSB YLTOR Z45 Z5O Z7U Z7V Z7W Z7X Z7Y Z81 Z83 Z87 ZMTXR ZOVNA ~A9 AACDK AAJBT AASML ABAKF ACAOD ACDTI ACMJI ACZOJ AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU CGR CUY CVF ECM EIF H13 LGEZI LOTEE NADUK NPM NXXTH SJYHP AAYXX CITATION 7X8 7QO 8FD FR3 P64 5PM |
ID | FETCH-LOGICAL-c541t-976373c8672bcd9aa41109b630e2703b35265014db2aedc465a734dee11cebea3 |
IEDL.DBID | RPM |
ISSN | 1530-9932 |
IngestDate | Tue Sep 17 21:18:04 EDT 2024 Sat Aug 17 00:01:34 EDT 2024 Tue Aug 27 04:53:07 EDT 2024 Thu Sep 12 17:14:44 EDT 2024 Sat Sep 28 07:51:12 EDT 2024 Sat Dec 16 12:01:21 EST 2023 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | SD SDD amorphous 96-well bioavailability HTPs solid dispersions spray dry |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c541t-976373c8672bcd9aa41109b630e2703b35265014db2aedc465a734dee11cebea3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 ObjectType-Feature-1 |
OpenAccessLink | https://europepmc.org/articles/pmc3364400?pdf=render |
PMID | 22562615 |
PQID | 1018350109 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3364400 proquest_miscellaneous_1113241890 proquest_miscellaneous_1018350109 crossref_primary_10_1208_s12249_012_9795_2 pubmed_primary_22562615 springer_journals_10_1208_s12249_012_9795_2 |
PublicationCentury | 2000 |
PublicationDate | 2012-06-01 |
PublicationDateYYYYMMDD | 2012-06-01 |
PublicationDate_xml | – month: 06 year: 2012 text: 2012-06-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Boston |
PublicationPlace_xml | – name: Boston – name: United States |
PublicationSubtitle | An Official Journal of the American Association of Pharmaceutical Scientists |
PublicationTitle | AAPS PharmSciTech |
PublicationTitleAbbrev | AAPS PharmSciTech |
PublicationTitleAlternate | AAPS PharmSciTech |
PublicationYear | 2012 |
Publisher | Springer US |
Publisher_xml | – name: Springer US |
References | Neirinckx, Vervaet, De Boever, Remon, Gommeren, Daminet, De Backer, Croubels (CR33) 2010; 89 Lipinski (CR2) 2002; 5 Bee, Rahman (CR23) 2010; 34 Al-Obaidi, Buckton (CR39) 2009; 10 Vasanthavada, Tong, Joshi, Kislalioglu (CR31) 2005; 22 Leuner, Dressman (CR7) 2000; 50 Broman, Khoo, Taylor (CR24) 2001; 222 CR11 CR30 Lipinski (CR4) 2003 Friesen, Shanker, Crew, Smithey, Curatolo, Nightingale (CR1) 2008; 5 Patel, Masnoon, Patel, Patel (CR18) 2009; 7 Lipinski (CR3) 2002; 44 Kalantzi, Reppas, Dressman, Amidon, Junginger, Midha, Shah, Stavchansky, Barends (CR34) 2006; 95 Al-Obaidi, Brocchini, Buckton (CR38) 2009; 98 Curatolo, Nightingale, Herbig (CR32) 2009; 26 Yoshioka, Hancock, Zografi (CR35) 1995; 84 Wenglowsky, Ren, Ahrendt, Laird, Aliagas, Alicke, Buckmelter, Choo, Dinkel, Feng, Gloor, Gould, Gross, Gunzner-Toste, Hansen, Hatzivassiliou, Liu, Malesky, Mathieu, Newhouse, Raddatz, Ran, Rana, Randolph, Risom, Rudolph, Savage, Selby, Shrag, Song, Sturgis, Voegtli, Wen, Willis, Woessner, Wu, Young, Grina (CR21) 2011; 2 Imaizumi (CR16) 1980; 29 Lipinski, Lombardo, Dominy, Feeney (CR14) 2001; 46 Thybo, Hovgaard, Lindelov, Brask, Andersen (CR26) 2008; 25 Taylor, Zografi (CR36) 1997; 14 Schroter (CR6) 2006; 9 Mansky, Dai, Li, Pollock-Dove, Daehne, Dong, Eichenbaum (CR19) 2007; 96 CR8 Gardner, Walsh, Almarsson (CR5) 2004; 3 CR22 Hancock, Parks (CR15) 2000; 17 Corrigan, Holohan, Reilly (CR29) 1985; 11 Shanbhag, Rabel, Nauka, Casadevall, Shivanand, Eichenbaum, Mansky (CR20) 2008; 351 Gao (CR10) 2008; 5 De Villiers, Wuster, Van der Watt, Ketkar (CR27) 1998; 163 DiNunzio, Miller, Yang, McGinity, Williams (CR13) 2008; 5 Gupta, Kakumanu, Bansal (CR12) 2004; 21 Damian, Blaton, Kinget, Van den Mooter (CR25) 2002; 244 Kaushal, Gupta, Bansal (CR17) 2004; 21 Ruben, Kiso, Freire (CR9) 2006; 67 Gong, Viboonkiat, Rehman, Buckton, Darr (CR28) 2005; 94 Rumondor, Marsac, Stanford, Taylor (CR37) 2009; 6 15553220 - Pharm Res. 2004 Oct;21(10):1762-9 15248808 - Crit Rev Ther Drug Carrier Syst. 2004;21(3):133-93 16307451 - J Pharm Sci. 2006 Jan;95(1):4-14 7500284 - J Pharm Sci. 1995 Aug;84(8):983-6 11404040 - Int J Pharm. 2001 Jul 3;222(1):139-51 15835750 - Pharm Res. 2005 Mar;22(3):440-8 20211479 - Res Vet Sci. 2010 Aug;89(1):113-9 19842041 - AAPS PharmSciTech. 2009;10(4):1172-7 19040386 - Mol Pharm. 2008 Nov-Dec;5(6):1003-19 16258991 - J Pharm Sci. 2005 Dec;94(12):2583-90 9453055 - Pharm Res. 1997 Dec;14(12):1691-8 18054181 - Int J Pharm. 2008 Mar 3;351(1-2):209-18 18404252 - Pharm Res. 2008 Jul;25(7):1610-20 7460092 - Chem Pharm Bull (Tokyo). 1980 Sep;28(9):2565-9 16492143 - Chem Biol Drug Des. 2006 Jan;67(1):2-4 19455622 - J Pharm Sci. 2009 Dec;98(12):4724-37 11259830 - Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26 10840192 - Eur J Pharm Biopharm. 2000 Jul;50(1):47-60 17094139 - J Pharm Sci. 2007 Jun;96(6):1548-63 11274893 - J Pharmacol Toxicol Methods. 2000 Jul-Aug;44(1):235-49 19634917 - Mol Pharm. 2009 Sep-Oct;6(5):1492-505 24900315 - ACS Med Chem Lett. 2011 Mar 08;2(5):342-7 15520815 - Nat Rev Drug Discov. 2004 Nov;3(11):926-34 19040385 - Mol Pharm. 2008 Nov-Dec;5(6):903-4 12204568 - Int J Pharm. 2002 Sep 5;244(1-2):87-98 19277850 - Pharm Res. 2009 Jun;26(6):1419-31 10870982 - Pharm Res. 2000 Apr;17(4):397-404 19434851 - Mol Pharm. 2008 Nov-Dec;5(6):968-80 S Wenglowsky (9795_CR21) 2011; 2 H Al-Obaidi (9795_CR39) 2009; 10 C Schroter (9795_CR6) 2006; 9 RC Patel (9795_CR18) 2009; 7 B Hancock (9795_CR15) 2000; 17 OI Corrigan (9795_CR29) 1985; 11 L Kalantzi (9795_CR34) 2006; 95 E Neirinckx (9795_CR33) 2010; 89 9795_CR8 P Mansky (9795_CR19) 2007; 96 CR Gardner (9795_CR5) 2004; 3 F Damian (9795_CR25) 2002; 244 9795_CR30 LS Taylor (9795_CR36) 1997; 14 AM Kaushal (9795_CR17) 2004; 21 9795_CR11 T Bee (9795_CR23) 2010; 34 P Gupta (9795_CR12) 2004; 21 CA Lipinski (9795_CR2) 2002; 5 MM Villiers De (9795_CR27) 1998; 163 M Yoshioka (9795_CR35) 1995; 84 HK Gong (9795_CR28) 2005; 94 P Gao (9795_CR10) 2008; 5 H Al-Obaidi (9795_CR38) 2009; 98 AC Rumondor (9795_CR37) 2009; 6 P Thybo (9795_CR26) 2008; 25 M Vasanthavada (9795_CR31) 2005; 22 C Leuner (9795_CR7) 2000; 50 AJ Ruben (9795_CR9) 2006; 67 DT Friesen (9795_CR1) 2008; 5 CA Lipinski (9795_CR3) 2002; 44 CA Lipinski (9795_CR4) 2003 A Shanbhag (9795_CR20) 2008; 351 JC DiNunzio (9795_CR13) 2008; 5 W Curatolo (9795_CR32) 2009; 26 C Lipinski (9795_CR14) 2001; 46 H Imaizumi (9795_CR16) 1980; 29 9795_CR22 E Broman (9795_CR24) 2001; 222 |
References_xml | – volume: 96 start-page: 1548 issue: 6 year: 2007 end-page: 1563 ident: CR19 article-title: Screening method to identify preclinical liquid and semi-solid formulations for low solubility compounds: miniaturization and automation of solvent casting and dissolution testing publication-title: J Pharm Sci doi: 10.1002/jps.20799 contributor: fullname: Eichenbaum – ident: CR22 – volume: 3 start-page: 926 year: 2004 end-page: 934 ident: CR5 article-title: Drugs as materials: valuing physical form in drug discovery publication-title: Nat Rev Drug Discov doi: 10.1038/nrd1550 contributor: fullname: Almarsson – volume: 5 start-page: 968 issue: 6 year: 2008 end-page: 980 ident: CR13 article-title: Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole publication-title: Mol Pharm doi: 10.1021/mp800042d contributor: fullname: Williams – volume: 7 start-page: 1918 issue: 6 year: 2009 end-page: 5561 ident: CR18 article-title: Formulation strategies for improving drug solubility using solid dispersions publication-title: Pharm Rev contributor: fullname: Patel – volume: 25 start-page: 1610 issue: 7 year: 2008 end-page: 1620 ident: CR26 article-title: Scaling up the spray drying process from pilot to production scale using an atomized droplet size criterion publication-title: Pharm Res doi: 10.1007/s11095-008-9565-8 contributor: fullname: Andersen – volume: 5 start-page: 1003 issue: 6 year: 2008 end-page: 1019 ident: CR1 article-title: Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview publication-title: Mol Pharm doi: 10.1021/mp8000793 contributor: fullname: Nightingale – volume: 95 start-page: 4 issue: 1 year: 2006 end-page: 14 ident: CR34 article-title: Biowaiver monographs for immediate release solid oral dosage forms: acetaminophen (paracetamol) publication-title: J Pharm Sci doi: 10.1002/jps.20477 contributor: fullname: Barends – ident: CR30 – volume: 5 start-page: 903 issue: 6 year: 2008 end-page: 904 ident: CR10 article-title: Amorphous pharmaceutical solids: characterization, stabilization, and development of marketable formulations of poorly soluble drugs with improved oral absorption publication-title: Mol Pharm doi: 10.1021/mp800203k contributor: fullname: Gao – volume: 10 start-page: 1172 issue: 4 year: 2009 end-page: 1177 ident: CR39 article-title: Evaluation of griseofulvin binary and ternary solid dispersions with HPMCAS publication-title: AAPS PharmSciTech doi: 10.1208/s12249-009-9319-x contributor: fullname: Buckton – volume: 17 start-page: 397 year: 2000 end-page: 404 ident: CR15 article-title: What is the true solubility advantage for amorphous pharmaceuticals? publication-title: Pharm Res doi: 10.1023/A:1007516718048 contributor: fullname: Parks – ident: CR8 – volume: 44 start-page: 235 year: 2002 end-page: 249 ident: CR3 article-title: Drug-like properties and the causes of poor solubility and poor permeability publication-title: J Pharmacol Toxicol Methods doi: 10.1016/S1056-8719(00)00107-6 contributor: fullname: Lipinski – volume: 11 start-page: 677 issue: 2&3 year: 1985 end-page: 695 ident: CR29 article-title: Physicochemical properties of indomethacin and related compounds co-spray dried with polyvinyl-pyrrolidone publication-title: Drug Dev Ind Pharm doi: 10.3109/03639048509056895 contributor: fullname: Reilly – volume: 34 start-page: 6 issue: 9 year: 2010 ident: CR23 article-title: Using polymer technology to enhance bioavailability publication-title: Pharm Technol contributor: fullname: Rahman – volume: 22 start-page: 440 issue: 3 year: 2005 end-page: 448 ident: CR31 article-title: Phase behavior of amorphous molecular dispersions II: role of hydrogen bonding in solid solubility and phase separation kinetics publication-title: Pharm Res doi: 10.1007/s11095-004-1882-y contributor: fullname: Kislalioglu – volume: 26 start-page: 1419 issue: 6 year: 2009 end-page: 1431 ident: CR32 article-title: Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu publication-title: Pharm Res doi: 10.1007/s11095-009-9852-z contributor: fullname: Herbig – volume: 163 start-page: 219 issue: 1–2 year: 1998 end-page: 224 ident: CR27 article-title: X-Ray powder diffraction determination of the relative amount of crystalline acetaminophen in solid dispersions with polyvinylpyrrolidone publication-title: Int J Pharm doi: 10.1016/S0378-5173(97)00367-0 contributor: fullname: Ketkar – year: 2003 ident: CR4 publication-title: Physicochemical properties and the discovery of orally active drugs: technical and people issues. Molecular informatics: confronting complexity. Proceedings of the Beilstein-Institut Workshop contributor: fullname: Lipinski – volume: 46 start-page: 3 year: 2001 end-page: 26 ident: CR14 article-title: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings publication-title: Adv Drug Deliv Rev doi: 10.1016/S0169-409X(00)00129-0 contributor: fullname: Feeney – volume: 9 start-page: 60 year: 2006 end-page: 67 ident: CR6 article-title: Prioritizing molecules based on physicochemical characteristics publication-title: Am Pharm doi: 10.1002/jps.3080090114 contributor: fullname: Schroter – volume: 94 start-page: 2583 issue: 12 year: 2005 end-page: 2590 ident: CR28 article-title: Formation and characterization of porous indomethacin-PVP coprecipitates prepared using solvent-free supercritical fluid processing publication-title: J Pharm Sci doi: 10.1002/jps.20474 contributor: fullname: Darr – volume: 6 start-page: 1492 issue: 5 year: 2009 end-page: 1505 ident: CR37 article-title: Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture publication-title: Mol Pharm doi: 10.1021/mp900050c contributor: fullname: Taylor – volume: 67 start-page: 2 year: 2006 end-page: 4 ident: CR9 article-title: Overcoming roadblocks in lead optimization: a thermodynamic perspective publication-title: Chem Biol Drug Des doi: 10.1111/j.1747-0285.2005.00314.x contributor: fullname: Freire – ident: CR11 – volume: 21 start-page: 133 year: 2004 end-page: 193 ident: CR17 article-title: Amorphous drug delivery systems: molecular aspects, design and performance publication-title: Crit Rev Ther Drug Carrier Syst doi: 10.1615/CritRevTherDrugCarrierSyst.v21.i3.10 contributor: fullname: Bansal – volume: 98 start-page: 4724 issue: 12 year: 2009 end-page: 4737 ident: CR38 article-title: Anomalous properties of spray dried solid dispersions publication-title: J Pharm Sci doi: 10.1002/jps.21782 contributor: fullname: Buckton – volume: 29 start-page: 983 year: 1980 end-page: 987 ident: CR16 article-title: Stability and several physical properties of amorphous and crystalline forms of indomethacin publication-title: Chem Pharm Bull(Tokyo) contributor: fullname: Imaizumi – volume: 222 start-page: 139 issue: 1 year: 2001 end-page: 151 ident: CR24 article-title: A comparison of alternative polymer excipients and processing methods for making solid dispersions of a poorly water soluble drug publication-title: Int J Pharm doi: 10.1016/S0378-5173(01)00709-8 contributor: fullname: Taylor – volume: 14 start-page: 1691 issue: 12 year: 1997 end-page: 1698 ident: CR36 article-title: Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions publication-title: Pharm Res doi: 10.1023/A:1012167410376 contributor: fullname: Zografi – volume: 2 start-page: 342 year: 2011 end-page: 347 ident: CR21 article-title: Pyrazolopyridine inhibitors of B-RafV600E. Part 1: the development of selective, orally bioavailable, and efficacious inhibitors publication-title: ACS Med Chem doi: 10.1021/ml200025q contributor: fullname: Grina – volume: 89 start-page: 113 issue: 1 year: 2010 end-page: 119 ident: CR33 article-title: Species comparison of oral bioavailability, first-pass metabolism and pharmacokinetics of acetaminophen publication-title: Res Vet Sci doi: 10.1016/j.rvsc.2010.02.002 contributor: fullname: Croubels – volume: 351 start-page: 209 year: 2008 end-page: 218 ident: CR20 article-title: Method for screening of solid dispersion formulations of low-solubility compounds—miniaturization and automation of solvent casting and dissolution testing publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2007.09.042 contributor: fullname: Mansky – volume: 5 start-page: 82 year: 2002 end-page: 85 ident: CR2 article-title: Poor aqueous solubility—an industry wide problem in drug discovery publication-title: Am Pharm contributor: fullname: Lipinski – volume: 50 start-page: 47 year: 2000 end-page: 60 ident: CR7 article-title: Improving drug solubility for oral delivery using solid dispersions publication-title: Eur J Pharm Biopharm doi: 10.1016/S0939-6411(00)00076-X contributor: fullname: Dressman – volume: 21 start-page: 1762 issue: 10 year: 2004 end-page: 1769 ident: CR12 article-title: Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective publication-title: Pharm Res doi: 10.1023/B:PHAM.0000045226.42859.b8 contributor: fullname: Bansal – volume: 244 start-page: 87 issue: 1–2 year: 2002 end-page: 98 ident: CR25 article-title: Physical stability of solid dispersions of the antiviral agent UC-781 with PEG 6000, Gelucire 44/14 and PVP K30 publication-title: Int J Pharm doi: 10.1016/S0378-5173(02)00316-2 contributor: fullname: Van den Mooter – volume: 84 start-page: 983 issue: 8 year: 1995 end-page: 986 ident: CR35 article-title: Inhibition of indomethacin crystallization in poly(vinylpyrrolidone) coprecipitates publication-title: J Pharm Sci doi: 10.1002/jps.2600840814 contributor: fullname: Zografi – volume: 163 start-page: 219 issue: 1–2 year: 1998 ident: 9795_CR27 publication-title: Int J Pharm doi: 10.1016/S0378-5173(97)00367-0 contributor: fullname: MM Villiers De – volume: 7 start-page: 1918 issue: 6 year: 2009 ident: 9795_CR18 publication-title: Pharm Rev contributor: fullname: RC Patel – ident: 9795_CR11 – volume: 5 start-page: 968 issue: 6 year: 2008 ident: 9795_CR13 publication-title: Mol Pharm doi: 10.1021/mp800042d contributor: fullname: JC DiNunzio – volume: 67 start-page: 2 year: 2006 ident: 9795_CR9 publication-title: Chem Biol Drug Des doi: 10.1111/j.1747-0285.2005.00314.x contributor: fullname: AJ Ruben – volume: 351 start-page: 209 year: 2008 ident: 9795_CR20 publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2007.09.042 contributor: fullname: A Shanbhag – volume: 25 start-page: 1610 issue: 7 year: 2008 ident: 9795_CR26 publication-title: Pharm Res doi: 10.1007/s11095-008-9565-8 contributor: fullname: P Thybo – volume: 84 start-page: 983 issue: 8 year: 1995 ident: 9795_CR35 publication-title: J Pharm Sci doi: 10.1002/jps.2600840814 contributor: fullname: M Yoshioka – volume: 5 start-page: 82 year: 2002 ident: 9795_CR2 publication-title: Am Pharm contributor: fullname: CA Lipinski – volume: 10 start-page: 1172 issue: 4 year: 2009 ident: 9795_CR39 publication-title: AAPS PharmSciTech doi: 10.1208/s12249-009-9319-x contributor: fullname: H Al-Obaidi – volume: 5 start-page: 903 issue: 6 year: 2008 ident: 9795_CR10 publication-title: Mol Pharm doi: 10.1021/mp800203k contributor: fullname: P Gao – volume: 89 start-page: 113 issue: 1 year: 2010 ident: 9795_CR33 publication-title: Res Vet Sci doi: 10.1016/j.rvsc.2010.02.002 contributor: fullname: E Neirinckx – volume: 26 start-page: 1419 issue: 6 year: 2009 ident: 9795_CR32 publication-title: Pharm Res doi: 10.1007/s11095-009-9852-z contributor: fullname: W Curatolo – volume: 34 start-page: 6 issue: 9 year: 2010 ident: 9795_CR23 publication-title: Pharm Technol contributor: fullname: T Bee – volume: 244 start-page: 87 issue: 1–2 year: 2002 ident: 9795_CR25 publication-title: Int J Pharm doi: 10.1016/S0378-5173(02)00316-2 contributor: fullname: F Damian – volume: 44 start-page: 235 year: 2002 ident: 9795_CR3 publication-title: J Pharmacol Toxicol Methods doi: 10.1016/S1056-8719(00)00107-6 contributor: fullname: CA Lipinski – volume: 95 start-page: 4 issue: 1 year: 2006 ident: 9795_CR34 publication-title: J Pharm Sci doi: 10.1002/jps.20477 contributor: fullname: L Kalantzi – volume: 46 start-page: 3 year: 2001 ident: 9795_CR14 publication-title: Adv Drug Deliv Rev doi: 10.1016/S0169-409X(00)00129-0 contributor: fullname: C Lipinski – volume: 96 start-page: 1548 issue: 6 year: 2007 ident: 9795_CR19 publication-title: J Pharm Sci doi: 10.1002/jps.20799 contributor: fullname: P Mansky – volume: 14 start-page: 1691 issue: 12 year: 1997 ident: 9795_CR36 publication-title: Pharm Res doi: 10.1023/A:1012167410376 contributor: fullname: LS Taylor – volume: 6 start-page: 1492 issue: 5 year: 2009 ident: 9795_CR37 publication-title: Mol Pharm doi: 10.1021/mp900050c contributor: fullname: AC Rumondor – ident: 9795_CR22 – volume: 94 start-page: 2583 issue: 12 year: 2005 ident: 9795_CR28 publication-title: J Pharm Sci doi: 10.1002/jps.20474 contributor: fullname: HK Gong – volume-title: Physicochemical properties and the discovery of orally active drugs: technical and people issues. Molecular informatics: confronting complexity. Proceedings of the Beilstein-Institut Workshop year: 2003 ident: 9795_CR4 contributor: fullname: CA Lipinski – volume: 3 start-page: 926 year: 2004 ident: 9795_CR5 publication-title: Nat Rev Drug Discov doi: 10.1038/nrd1550 contributor: fullname: CR Gardner – ident: 9795_CR8 – volume: 17 start-page: 397 year: 2000 ident: 9795_CR15 publication-title: Pharm Res doi: 10.1023/A:1007516718048 contributor: fullname: B Hancock – volume: 98 start-page: 4724 issue: 12 year: 2009 ident: 9795_CR38 publication-title: J Pharm Sci doi: 10.1002/jps.21782 contributor: fullname: H Al-Obaidi – volume: 222 start-page: 139 issue: 1 year: 2001 ident: 9795_CR24 publication-title: Int J Pharm doi: 10.1016/S0378-5173(01)00709-8 contributor: fullname: E Broman – volume: 9 start-page: 60 year: 2006 ident: 9795_CR6 publication-title: Am Pharm doi: 10.1002/jps.3080090114 contributor: fullname: C Schroter – volume: 29 start-page: 983 year: 1980 ident: 9795_CR16 publication-title: Chem Pharm Bull(Tokyo) contributor: fullname: H Imaizumi – volume: 21 start-page: 133 year: 2004 ident: 9795_CR17 publication-title: Crit Rev Ther Drug Carrier Syst doi: 10.1615/CritRevTherDrugCarrierSyst.v21.i3.10 contributor: fullname: AM Kaushal – volume: 11 start-page: 677 issue: 2&3 year: 1985 ident: 9795_CR29 publication-title: Drug Dev Ind Pharm doi: 10.3109/03639048509056895 contributor: fullname: OI Corrigan – volume: 50 start-page: 47 year: 2000 ident: 9795_CR7 publication-title: Eur J Pharm Biopharm doi: 10.1016/S0939-6411(00)00076-X contributor: fullname: C Leuner – volume: 2 start-page: 342 year: 2011 ident: 9795_CR21 publication-title: ACS Med Chem doi: 10.1021/ml200025q contributor: fullname: S Wenglowsky – volume: 5 start-page: 1003 issue: 6 year: 2008 ident: 9795_CR1 publication-title: Mol Pharm doi: 10.1021/mp8000793 contributor: fullname: DT Friesen – volume: 21 start-page: 1762 issue: 10 year: 2004 ident: 9795_CR12 publication-title: Pharm Res doi: 10.1023/B:PHAM.0000045226.42859.b8 contributor: fullname: P Gupta – ident: 9795_CR30 – volume: 22 start-page: 440 issue: 3 year: 2005 ident: 9795_CR31 publication-title: Pharm Res doi: 10.1007/s11095-004-1882-y contributor: fullname: M Vasanthavada |
SSID | ssj0023193 |
Score | 2.2167842 |
Snippet | It is well recognized that poor dissolution rate and solubility of drug candidates are key limiting factors for oral bioavailability. While numerous... |
SourceID | pubmedcentral proquest crossref pubmed springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 713 |
SubjectTerms | Acetaminophen - chemistry Bioavailability Biochemistry Biomedical and Life Sciences Biomedicine Biotechnology Celecoxib Chemistry, Pharmaceutical Crystallization Dissolution Drug Carriers Drug delivery Drug development Drug Stability Drying Equipment Design Griseofulvin - chemistry high-throughput screening High-Throughput Screening Assays - instrumentation High-Throughput Screening Assays - standards Hypromellose Derivatives Indomethacin - chemistry Kinetics Limiting factors Methylcellulose - analogs & derivatives Methylcellulose - chemistry Miniaturization Pharmaceutical Preparations - chemistry Pharmacology/Toxicology Pharmacy Polymers - chemistry Povidone - chemistry Pyrazoles - chemistry Quality Control Reproducibility of Results Research Article Solubility Solvents Solvents - chemistry Sulfonamides - chemistry Technology, Pharmaceutical - instrumentation Technology, Pharmaceutical - methods Technology, Pharmaceutical - standards Vacuum Water - chemistry |
SummonAdditionalLinks | – databaseName: SpringerLINK - Czech Republic Consortium dbid: AGYKE link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELem7oUXYOOrMKZDQnuApST-iJPHinZMgFAlNhhPkZM4o1qaTE3zkPHPc3bSTKWAtOfYju58Pv_Od_6ZkNcYM3CRKlzfbqYcrmnqhEIqJ6Ms9qjnI8K1bJ9f_NNz_vFCXOwQ2h9dFFejdUbSOmpLgOAG7yqTAjKlPdQJZSgcdLu7wrxKPSC74w8_Pk37MAuNinX5y7923NyBtmDldnXkHylSu_OcPGhvA1aWsNAUnFyN6lU8Sm626RzvINRDcr8DojBuLWeP7OhinxzNWibr5hjObi9mVcdwBLNbjuvmEfk17VnCocxgsqwv4XOpUlBFCrMybxZ6CXEDtiIBFIS-813nOcxyxLbwTSV1vcBeDbSM6YDQGcaLEie9rCv4WubzFCZzw2JuTvPa8Sc6N0UkzWNyfjI9e3_qdO84OIng3gpF85lkSeBLGidpqBQ3NKexz1xN0eHElqIfQ7U0pgrVzn2hJOOp1p6XoI0p9oQMirLQzwgkIsiEkAnVCCuU5sqVYSy58hFJZor7Q_JmPbfRdUvXEZkwB5UdtcqOUNmRUXZEh-TVevYjXFQmU6IKjWKaurfAZFzd8D9tPAzkuReE7pA8bS2m_yU6SQwUPTEkcsOW-gaG1HvzSzH_acm9GUOE6uKYb9cWE3Vepfq3JM_v1PoFuUeNydmzpAMyWC1r_RKh1So-7NbSb8FIHMY priority: 102 providerName: Springer Nature |
Title | Evaluation of Drug Load and Polymer by Using a 96-Well Plate Vacuum Dry System for Amorphous Solid Dispersion Drug Delivery |
URI | https://link.springer.com/article/10.1208/s12249-012-9795-2 https://www.ncbi.nlm.nih.gov/pubmed/22562615 https://search.proquest.com/docview/1018350109 https://search.proquest.com/docview/1113241890 https://pubmed.ncbi.nlm.nih.gov/PMC3364400 |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9QwFLbacuGCKGtYqoeEeoCmk3iJk-OoM6ViUyQ6UE6RnTgwUpZqZnKI-ud5zjKlVHDgkksWx_6e7e_5PX8m5DX6DFxkCvu3lyuXG5q5kZDKzSnTPvUDZLid2ufn4GzB31-Iix0ixr0wXdJ-qpfHVVEeV8ufXW7lZZlOxjyxSfzphDGcxT1vskt2JWOjiz54WWhTbAhfUi-crG3oyKYEUTeSkXDt8TVow8jj7Um4v89Ftwjm7TzJP4Kl3Rx0ep_cG8gjTPuf3Cc7pnpADuNefbo9gvPrzVTrIziE-FqXun1IruZbZW-oc5itmh_wsVYZqCqDuC7a0qxAt9BlEYCCKHC_maKAuEA-Cl9V2jQlvtVCr3IOSHdhWtYIVN2s4UtdLDOYLa3yuF2B678_M4VN_GgfkcXp_PzkzB3OXnBTwf0NtlXAJEvDQFKdZpFS3EqT6oB5huIgoTtZfXSvMk0VNhAPhJKMZ8b4fop2odhjslfVlXlKIBVhLoRMqUEqoAxXnoy05CpA9pcrHjjkzYhCctlLbCTWNUH0kh69BNFLLHoJdcirEacEO4KNbqjKYDVtrlpoo6Re9I9nfHS-uR9GnkOe9NhuixyNwiHyBurbB6wQ9807aJ-dIPdgjw55O9pHMowE67_X5Nl_l_Oc3KXWnru1oBdkb7NqzEukRht9QO5M333_MD_ougReF3T6CynmD5Q |
link.rule.ids | 230,315,733,786,790,891,27957,27958,41116,41558,42185,42627,52146,52269,53827,53829 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwELbQcoALWpZXl8cOEtoDbETiV5JjRXdVoKwq0cLeLCdxoFKaoKY5RPx5xk7SVVlA4hzHkf2Nx994xl8IeYUxAxeZxvXt59rjhmZeLELt5ZQlAQ0kMlyn9nkpp0v-4Upc9fe466HafUhJOk_tFBD86G1tc0C2tod6cRgLD_3ubSunbiOuJR3voiy0KdanL__42v4GdINV3iyO_C1D6jaei0Nyr2eMMO4gvk9umfKInM47yen2DBbXN6jqMziF-bUYdfuA_DzfyXlDlcNk03yDWaUz0GUG86po12YDSQuudAA0xNL7aooC5gWSUPii06ZZ41stdNLmgBwXxusK0amaGj5XxSqDycrKjdtjt67_iSlstUf7kCwvzhfvpl7_wwUvFTzY4gRJFrI0kiFN0izWmls90kQy31D0DInT0seYKkuoxgniUuiQ8cyYIEjRGDR7RA7KqjRPCKQiyoUIU2pw_9eGaz-Mk5BriZQv11yOyOsBBfWj09VQNh5ByFQHmULIlIVM0RF5OeCk0PptSkOXBodpC9Qimxr143-0CTDi5kEU-yPyuMN290n0ZhjRBWJEwj3Udw2s-vb-k3L13alwM4ZU0sc-3wz2ofrlX_99JMf_1fqE3JkuPs3U7P3lx6fkLrVG7A6AnpGD7aYxz5EPbZMXzv5_AQCCA8s |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZQKyEuvB9bXoOEeoCmTRw7j-OK3aXQqopEC-XkOokDq2aTapMcAn-ecZxstS0gIc6xHY392f7GM_5MyGv0GRhPJc5vO5MWUzS1Qu5LK6Nu7FDHQ4bbqX0eefsn7OMpP-3fOa2GbPchJGnuNGiVpqLeu0gzo4ZgB3uVjgfpPB9qhX7ILVyDNxnOWoT45vj914PpyudChLl9MPO3Fde3o2sc83qq5JV4abcNze6Qs8EAk31yvtvU8W7y44q2439YeJfc7ikqjA2m7pEbqrhPtiOjcd3uwPHlla1qB7YhulS_bh-Qn9OVfjiUGUyWzTc4LGUKskghKvN2oZYQt9DlKoCE0LO-qDyHKEfWC59l0jQLrNWC0VIHJNUwXpQIh7Kp4FOZz1OYzLW-uT7nM-1PVK7TS9qH5GQ2PX63b_UvPFgJZ06Npnmu7yaB59M4SUMpmRZAjT3XVhSXorgT70cnLo2pxDFgHpe-y1KlHCdB9En3EdkoykI9IZDwIOPcT6hCwiEVk7Yfxj6THnLMTDJvRN4MAy0ujJCH0A4QdrYwnS2ws4XubEFH5NUABYHTTcdQZKHQTJ0RF-hYrB3-pYyDLj5zgtAekccGPqtf4vKJLqTDR8RfA9aqgJb7Xv9SzL93st-ui9zVxjbfDugR_XpT_dmSrX8q_ZLcjCYzcfjh6OApuUU1-roDp2dko1426jnyrzp-0c-xX_daKXU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+drug+load+and+polymer+by+using+a+96-well+plate+vacuum+dry+system+for+amorphous+solid+dispersion+drug+delivery&rft.jtitle=AAPS+PharmSciTech&rft.au=Chiang%2C+Po-Chang&rft.au=Ran%2C+Yingqing&rft.au=Chou%2C+Kang-Jye&rft.au=Cui%2C+Yong&rft.date=2012-06-01&rft.eissn=1530-9932&rft.volume=13&rft.issue=2&rft.spage=713&rft.epage=722&rft_id=info:doi/10.1208%2Fs12249-012-9795-2&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1530-9932&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1530-9932&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1530-9932&client=summon |